Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Development and Validation of Circulating Tumour Cell Enumeration (Epic Sciences) as a Prognostic Biomarker in Men With Metastatic Castration-Resistant Prostate CancerEur. J. Cancer 2021 Jun 01;150(xx)83-94, HI Scher, AJ Armstrong, JD Schonhoft, A Gill, JL Zhao, E Barnett, E Carbone, J Lu, ES Antonarakis, J Luo, S Tagawa, CH Dos Anjos, Q Yang, D George, R Szmulewitz, DC Danila, R Wenstrup, M Gonen, S Halabi
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.